A. Baki Agbas in Mitochondrial Dysfunction 491 Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients
A. Baki Agbas in Mitochondrial Dysfunction 501 Mitochondrial dysfunction in amyotrophic lateral sclerosis-a valid pharmacological target
A. Baki Agbas in Mitochondrial Dysfunction 479 Misfolded Mutant SOD1 Directly Inhibits VDAC1 conductance in a mouse model of inherited ALS
A. Baki Agbas in Mitochondrial Dysfunction 464 Is Amyotrophic Lateral Sclerosis a mitochondrial channelopathy
A. Baki Agbas in Mitochondrial Dysfunction 481 Elevated PGC-1alpha activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS
A. Baki Agbas in Mitochondrial Dysfunction 471 Toxicity of Familial ALS-Linked SOD1 Mutants from selective recruitment to spinal mitochondria
A. Baki Agbas in Mitochondrial Dysfunction 485 Oxidative stress and mitochondrial damage in the pathogenesis of ALS-New perspectives
A. Baki Agbas in Mitochondrial Dysfunction 4801 The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity
A. Baki Agbas in Mitochondrial Dysfunction 5101 New therapeutic avenue for ALS_ Avoiding a fatal encounter of TDP-43 at the mitochondria
